Coagulation changes and thromboembolic risk in COVID-19 obstetric patients

Anaesth Crit Care Pain Med. 2020 Jun;39(3):351-353. doi: 10.1016/j.accpm.2020.05.003. Epub 2020 May 11.
No abstract available

Keywords: Coagulation; Fibrinolysis; Haemorrhage; Hypercoagulability; Pregnancy; Regional anaesthesia.

Publication types

  • Review

MeSH terms

  • Anticoagulants / therapeutic use
  • Autoantibodies / blood
  • Betacoronavirus* / isolation & purification
  • Betacoronavirus* / physiology
  • Blood Proteins / analysis
  • COVID-19
  • Cerebrovascular Disorders / etiology
  • Cerebrovascular Disorders / prevention & control
  • Contraindications, Drug
  • Coronavirus Infections / blood*
  • Coronavirus Infections / complications
  • Cytokine Release Syndrome / blood
  • Cytokine Release Syndrome / etiology
  • Disseminated Intravascular Coagulation / drug therapy
  • Disseminated Intravascular Coagulation / etiology
  • Endothelial Cells / virology
  • Female
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Pandemics*
  • Partial Thromboplastin Time
  • Plasma
  • Pneumonia, Viral / blood*
  • Pneumonia, Viral / complications
  • Postpartum Hemorrhage / drug therapy
  • Postpartum Hemorrhage / therapy
  • Pregnancy
  • Pregnancy Complications, Hematologic / drug therapy
  • Pregnancy Complications, Hematologic / etiology*
  • Pregnancy Complications, Infectious / blood*
  • Puerperal Disorders / blood
  • Puerperal Disorders / drug therapy
  • Puerperal Disorders / etiology
  • SARS-CoV-2
  • Thromboembolism / etiology
  • Thromboembolism / prevention & control*
  • Thrombophilia / drug therapy
  • Thrombophilia / etiology*
  • Tranexamic Acid / adverse effects
  • Tranexamic Acid / therapeutic use

Substances

  • Anticoagulants
  • Autoantibodies
  • Blood Proteins
  • Heparin, Low-Molecular-Weight
  • Tranexamic Acid